CAROLINE MAULDIN: Open Payments
NPI 1457597080 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,358 in 69 payments from 20 companies in 2025. Trend: 2023 $387 · 2024 $1,443 · 2025 $4,358
Travel & lodging: $2,388Food & beverage: $1,969
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 16 | $1,918 |
| Boston Scientific Corporation | 10 | $1,278 |
| United Therapeutics Corporation | 4 | $260 |
| Actelion Pharmaceuticals US, Inc. | 4 | $184 |
| PFIZER INC. | 8 | $157 |
| Merck Sharp & Dohme LLC | 4 | $97 |
| Regeneron Healthcare Solutions, Inc. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| HEARTFLOW, INC. | 2 | $40 |
Products named: CARDIOMEMS, General - Structural Heart, UPTRAVI, Tyvaso, EVKEEZA, VYNDAQEL, LEQVIO, ELIQUIS.
Industry payments across AL — which companies pay providers there.
